Skip to main content
OpenTrials

Clinical trial condition

Eye Diseases, Hereditary

Explore clinical trials studying Eye Diseases, Hereditary. Study availability and eligibility vary by location and protocol.

29 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Eye Diseases, Hereditary trial results

Active, Not Recruiting

A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001

NCT06852963

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases Hereditary, +7 more
Locations
  • University of Florida College of Medicine Jacksonville, Florida, United States
  • Bascom Palmer Eye Institute - University of Miami Miami, Florida, United States
  • Kellogg Eye Center - University of Michigan Ann Arbor, Michigan, United States
  • Casey Eye Institute - OHSU Portland, Oregon, United States
View Trial Details
Active, Not Recruiting

Natural History of PRPF31 Mutation-Associated Retinal Dystrophy

NCT05573984

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +7 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • University of Florida Health Jacksonville, Florida, United States
  • University of Michigan Kellogg Eye Center Ann Arbor, Michigan, United States
  • Oregon Health and Science University - Casey Eye Institute Portland, Oregon, United States
View Trial Details
Active, Not Recruiting

Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa

NCT03326336

Conditions
Cone-Rod Dystrophies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +7 more
Locations
  • UPMC Eye Center Pittsburgh, Pennsylvania, United States
  • Centre Hospitalier National d'Ophtalmologie (CHNP) des Quinze-Vingts Paris, France
  • Moorfields Eye Hospital NHS Foundation Trust, 162 City Road London, United Kingdom
View Trial Details
Active, Not Recruiting

Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F

NCT04765345

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Deafness, Autosomal Recessive 23, Eye Diseases, +6 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • The Johns Hopkins Wilmer Eye Institute Baltimore, Maryland, United States
  • Duke University, Duke Eye Center Durham, North Carolina, United States
  • Hospital for Sick Children Toronto, Ontario, Canada
View Trial Details
Active, Not Recruiting

Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study

NCT06162585

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +13 more
Locations
  • Nanoscope Clinical Site Beverly Hills, California, United States
  • Nanoscope Clinical Site Pensacola, Florida, United States
  • Nanoscope Clinical Site Fargo, North Dakota, United States
  • Nanoscope Clinical Site Houston, Texas, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene

NCT04123626

Conditions
Autosomal Dominant Retinitis Pigmentosa, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +17 more
Locations
  • Sue Anschutz-Rogers Eye Center, University of Colorado - Dept. of Ophthalmology Aurora, Colorado, United States
  • VitreoRetinal Associates Gainesville, Florida, United States
  • Shriners UK Ophthalmology - University of Kentucky Lexington, Kentucky, United States
  • Casey Eye Institute, OHSU Portland, Oregon, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)

NCT03913143

Conditions
Blindness, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +26 more
Locations
  • University of Iowa Iowa City, Iowa, United States
  • Universitair Ziekenhuis Gent (UZ) Ghent, Belgium
  • INRET Clínica/ Santa Casa de Misericórdia de Belo Horizonte Belo Horizonte, Minas Gerais, Brazil
  • Federal University of São Paulo - Hospital São Paulo (UNIFESP-HSP) São Paulo, Brazil
View all 14 locations
View Trial Details

Related conditions